Pathology of non‐alcoholic fatty liver disease von Bedossa, Pierre

Volltext

Diagnosis of non‐alcoholic fatty liver disease/non‐alcoholic steatohepatitis: Why liver biopsy is essential von Bedossa, Pierre

Volltext

Reversibility of hepatitis B virus cirrhosis after therapy: who and why? von Bedossa, Pierre

Volltext

Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease von Bedossa, Pierre, Patel, Keyur

Volltext

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalco... von Bedossa, Pierre

Volltext

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement von Eslam, Mohammed, Newsome, Philip N., Sarin, Shiv K., Anstee, Quentin M., Targher, Giovanni, Romero-Gomez, Manuel, Zelber-Sagi, Shira, Wai-Sun Wong, Vincent, Dufour, Jean-François, Schattenberg, Jörn M., Kawaguchi, Takumi, Arrese, Marco, Valenti, Luca, Shiha, Gamal, Tiribelli, Claudio, Yki-Järvinen, Hannele, Fan, Jian-Gao, Grønbæk, Henning, Yilmaz, Yusuf, Cortez-Pinto, Helena, Oliveira, Claudia P., Bedossa, Pierre, Adams, Leon A., Zheng, Ming-Hua, Fouad, Yasser, Chan, Wah-Kheong, Mendez-Sanchez, Nahum, Ahn, Sang Hoon, Castera, Laurent, Bugianesi, Elisabetta, Ratziu, Vlad, George, Jacob

Volltext

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients von Bedossa, Pierre, Poitou, Christine, Veyrie, Nicolas, Bouillot, Jean-Luc, Basdevant, Arnaud, Paradis, Valerie, Tordjman, Joan, Clement, Karine

Volltext

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease von Kumar, Divya P., Caffrey, Rebecca, Marioneaux, Jonathon, Santhekadur, Prasanna K., Bhat, Madhavi, Alonso, Cristina, Koduru, Srinivas V., Philip, Binu, Jain, Mukul R., Giri, Suresh R., Bedossa, Pierre, Sanyal, Arun J.

Volltext

A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH von Francque, Sven M, Bedossa, Pierre, Ratziu, Vlad, Anstee, Quentin M, Bugianesi, Elisabetta, Sanyal, Arun J, Loomba, Rohit, Harrison, Stephen A, Balabanska, Rozalina, Mateva, Lyudmila, Lanthier, Nicolas, Alkhouri, Naim, Moreno, Christophe, Schattenberg, Jörn M, Stefanova-Petrova, Diana, Vonghia, Luisa, Rouzier, Régine, Guillaume, Maeva, Hodge, Alexander, Romero-Gómez, Manuel, Huot-Marchand, Philippe, Baudin, Martine, Richard, Marie-Paule, Abitbol, Jean-Louis, Broqua, Pierre, Junien, Jean-Louis, Abdelmalek, Manal F

Volltext

Liver Histology and Clinical Trials for Nonalcoholic Steatohepatitis-Perspectives From 2 Pathologists von Kleiner, David E, Bedossa, Pierre

Volltext

Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion von Poté, Nicolas, Cauchy, François, Albuquerque, Miguel, Voitot, Hélène, Belghiti, Jacques, Castera, Laurent, Puy, Hervé, Bedossa, Pierre, Paradis, Valérie

Volltext

A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer von Asgharpour, Amon, Cazanave, Sophie C, Pacana, Tommy, Seneshaw, Mulugeta, Vincent, Robert, Banini, Bubu A, Kumar, Divya Prasanna, Daita, Kalyani, Min, Hae-Ki, Mirshahi, Faridoddin, Bedossa, Pierre, Sun, Xiaochen, Hoshida, Yujin, Koduru, Srinivas V, Contaifer, Daniel, Warncke, Urszula Osinska, Wijesinghe, Dayanjan S, Sanyal, Arun J

Volltext

Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease von Musolino, Vincenzo, Gliozzi, Micaela, Scarano, Federica, Bosco, Francesca, Scicchitano, Miriam, Nucera, Saverio, Carresi, Cristina, Ruga, Stefano, Zito, Maria Caterina, Maiuolo, Jessica, Macrì, Roberta, Amodio, Nicola, Juli, Giada, Tassone, Pierfrancesco, Mollace, Rocco, Caffrey, Rebecca, Marioneaux, Jonathon, Walker, Ross, Ehrlich, James, Palma, Ernesto, Muscoli, Carolina, Bedossa, Pierre, Salvemini, Daniela, Mollace, Vincenzo, Sanyal, Arun J.

Volltext

Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis von Karlas, Thomas, Petroff, David, Sasso, Magali, Fan, Jian-Gao, Mi, Yu-Qiang, de Lédinghen, Victor, Kumar, Manoj, Lupsor-Platon, Monica, Han, Kwang-Hyub, Cardoso, Ana C, Ferraioli, Giovanna, Chan, Wah-Kheong, Wong, Vincent Wai-Sun, Myers, Robert P, Chayama, Kazuaki, Friedrich-Rust, Mireen, Beaugrand, Michel, Shen, Feng, Hiriart, Jean-Baptiste, Sarin, Shiv K, Badea, Radu, Jung, Kyu Sik, Marcellin, Patrick, Filice, Carlo, Mahadeva, Sanjiv, Wong, Grace Lai-Hung, Crotty, Pam, Masaki, Keiichi, Bojunga, Joerg, Bedossa, Pierre, Keim, Volker, Wiegand, Johannes

Volltext

A prospective study of the utility of plasma biomarkers to diagnose alcoholic hepatitis von Bissonnette, Julien, Altamirano, José, Devue, Cécile, Roux, Olivier, Payancé, Audrey, Lebrec, Didier, Bedossa, Pierre, Valla, Dominique, Durand, François, Ait‐Oufella, Hafid, Sancho‐Bru, Pau, Caballeria, Joan, Ginès, Pere, Boulanger, Chantal M., Bataller, Ramon, Rautou, Pierre‐Emmanuel

Volltext

Sampling variability of liver fibrosis in chronic hepatitis C von Bedossa, Pierre, Dargère, Delphine, Paradis, Valerie

Volltext

Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: A multicenter prospective study (the FIBROSTIC study) von Degos, Francoise, Perez, Paul, Roche, Bruno, Mahmoudi, Amel, Asselineau, Julien, Voitot, Hélène, Bedossa, Pierre

Volltext

Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science von Siddiqui, Mohammad Shadab, Harrison, Stephen A., Abdelmalek, Manal F., Anstee, Quentin M., Bedossa, Pierre, Castera, Laurent, Dimick‐Santos, Lara, Friedman, Scott L., Greene, Katherine, Kleiner, David E., Megnien, Sophie, Neuschwander‐Tetri, Brent A., Ratziu, Vlad, Schabel, Elmer, Miller, Veronica, Sanyal, Arun J.

Volltext

Obesity and Fatty Pancreatic Infiltration Are Risk Factors for Pancreatic Precancerous Lesions (PanIN) von Rebours, Vinciane, Gaujoux, Sébastien, d'Assignies, Gaspard, Sauvanet, Alain, Ruszniewski, Philippe, Lévy, Philippe, Paradis, Valérie, Bedossa, Pierre, Couvelard, Anne

Volltext

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis von Sanyal, Arun J., Bedossa, Pierre, Fraessdorf, Mandy, Neff, Guy W., Lawitz, Eric, Bugianesi, Elisabetta, Anstee, Quentin M., Hussain, Samina Ajaz, Newsome, Philip N., Ratziu, Vlad, Hosseini-Tabatabaei, Azadeh, Schattenberg, Jörn M., Noureddin, Mazen, Alkhouri, Naim, Younes, Ramy

Volltext